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ABSTRACT: Possible predictors of reported lower cognitive functioning in irradiated children with acute lympho-
blastic leukemia (ALL) were investigated. Thirty-four subjects, 5-14 years old, with ALL in continuous complete 
remission and without evidence of current or past central nervous system disease, were examined 9-11 O months 
after diagnosis, using standard measures of intelligence and academic achievement. Subjects with a history 
of post-irradiation somnolence syndrome were significantly older at diagnosis than nonsomnolent subjects. 
Intelligence (IQ) was found to be unrelated to history of somnolence syndrome. IQ and achievement were unrelated 
to age at irradiation, irradiation-examination interval, and radiation dosages. The strongest predictor ot IQ by 
far is parental social class. The importance of controlling for social class differences when searching for treat-
ment effects on IQ and achievement is stressed. J Dev Behav Pediatr 9:122-128, 1988. Index terms: lymphoblastic 
leukemia, cranial irradiation, somnolence syndrome, intelligence, achievement. 
Prophylactic cranial irradiation and improved 
chemotherapy have greatly decreased the incidence of cen-
tral nervous system (CNS) leukemia and increased survival 
rates in children with acute lymphoblastic leukemia (ALL) 
in the last 15 years.1 Interest has shifted to the quality of 
psychological survival in these children, and particularly to 
effects of CNS irradiation on intelligence (IQ) and achieve-
ment. This paper examines factors that might be expected to 
contribute to present or future intellectual difficulties in 
ALL patients. Four have been suggested: 
I. Post-irradiation somnolence syndrome. Ch'ien et al2 
reported seizures and "learning difficulties," definep as 
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"dull normal intelligence, short attention span and poor 
recent memory," in children who had a history of som-
nolence syndrome, but not in children without such a 
history. This syndrome is characterized by drowsiness 
and lethargy occurring 3-8 weeks after the end of cranial 
irradiation3 and was first observed by Druckmann4 in 
children receiving low dose cranial irradiation for tinea 
capitis. 
2. Age at irradiation. The younger, incompletely mye-
linated brain may be more vulnerable to irradiation. 5 
Three reports have demonstrated a relationship between 
young age at irradiation and low IQ;6· 8 four have failed 
to demonstrate a significant relationship.9- 12 
3. IrradiatiOn-examination interval. fotellectual pertor-
mance has been reported to be significantly diminished 3 
years, but not I year, after irradiation.13-is In contrast, no 
significant correlation between long irradiation-
examination interval and IQ was found by Robinson et 
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4. Radiation dosage. Supposing that radiation damages 
the brain, it is logical to hypothesize poorer outcome in 
patients receiving more radiation. No correlation be-
tween radiation dosage and measures of IQ, visual-
motor integration, attention, concentration, or short-
term memory has been found in two previous studies.10.16 
The present study was undertaken to examine the effects 
of somnolence syndrome, age at irradiation, irradiation-
examination interval, and radiation dosage on IQ and aca-
demic achievement of children with leukemia in con-
tinuous, complete remission. This study differs from 
previously published reports in that (a) it includes a total 
patient population selected only for age at examination, (b) 
the same measures are used in all subjects, (c) it excludes 
subjects with other possible causes of low IQ, and (d) it 
statistically controls for social class differences. 
METHODS 
Sample 
The subjects of this study included every patient with 
acute lymphoblastic leukemia (ALL) who was (1) between 
the ages of 5 and 14, (2) without evidence at any time of cen-
tral nervous system (CNS) or systemic relapse of leukemia, 
and (3) without history of CNS disease (including en-
cephalitis, meningitis, and seizui:e disorders), or Down syn-
drome. Of 43 children meeting the first two criteria, four 
were excluded because of central nervous system (CNS) 
disease or Down syndrome leaving 39 who met all three 
criteria (including one child who had a single febrile seizure 
in infancy, years prior to diagnosis). Thirty-three were fully 
studied: one child, age 5, refused to talk but completed 
nonverbal psychometric tests; four parents completed a 
behavioral questionnaire (not reported on here) only; and 
one family refused to participate at all. Twelve of the 39 
subjects were still receiving chemotherapy at the time of 
examination. All subjects attended the Pediatric 
Hematology-Oncology Clinic in the Babies Hospital of the 
Presbyterian Hospital in the City of New York, or an af-
filiated hospital. Subjects were treated with Children's 
Cancer Study Group Protocols 101, 141, 14la, 161, 162, 
163, or 905. 11- 23 Subjects were 14-139 months old at 
diagnosis (mean 60.1, median 55.5) and were examined 
9-110 months (mean 49.0, median 45.0) later. All had been 
irradiated (1800 or 2400 rads) within 2 months of diagnosis. 
Therefore, in this report, "time since diagnosis" and "time 
since irradiation" are virtually equivalent. A minimum in-
terval of 6 months between diagnosis and examination was 
chosen on the assumption that most children will have 
recovered from the acute illness and returned to school by 
that time. 
Measures 
1. Psychometric testing. Subjects were tested by experi-
enced psychometricians who knew that the children were 
in continuous complete remission but were blind to the 
hypotheses of the study and to history of somnolence, 
age at irradiation, and radiation dosage. An age-
appropriate Wechsler intelligence test (WISC-R,24 or 
WPPSl25) and the reading comprehension, spelling, and 
mathematics subtests of the Peabody Individual 
Achievement Test26 were administered. 
2. Social class. The Hollingshead Four Factor Index of 
parental education and employment was used to deter-
mine social class (social class: 1 =highest, 5 = lowest).27 
3. Assessment of somnolence. Each subject's chart was 
searched for symptoms of somnolence syndrome 2•3 in 
the notes that had been recorded at weekly to monthly 
clinic visits during the 4 months after the start of cranial 
irradiation. If the child was rehospitalized during this 
period, daily progress and nursing notes were reviewed. 
A diagnosis of somnolence syndrome was made if the 
examining physician had specifically noted the presence 
of the syndrome or if the words "drowsiness" or 
"lethargy" or a synonym of these appeared in the record 
during the third through eighth weeks after the end of 
cranial irradiation. We excluded symptoms of som-
nolence occurring before the third week (three cases, of 
which two occurred during the course of irradiation and 
one after), as well as symptoms which could be at-
tributed to other causes, e.g., intercurrent infection or 
drug side effects. In no case did somnolence symptoms 
begin after the eighth week, but in five cases, symptoms 
persisted beyond the eighth week. 
Procedure 
Informed consent was obtained from a parent in the 
presence of the child. Psychometric testing and other 
measures (to be reported elsewhere) usually were completed 
in a single morning or afternoon session. Children were not 
tested on a day when lumbar puncture or bone marrow 
examination was scheduled, and psychometric testing 
usually preceded other measures. 
Medical records were surveyed twice for symptoms of 
somnolence syndrome and the abstracts were checked for 
accuracy. Assignment to the somnolent or nonsomnolerit 
groups was made from the abstracts independently by three 
of us (PT, CE, AC) who were blind to the identity of the 
subject and psychometric test results, but not to age at 
diagnosis or radiation dosage. Where disagreement oc-
curred (11 of 34 cases), we reviewed abstracts and medical 
records together and reached a consensus, in every instance 
rating doubtful cases as nonsomnolent. This procedure was 
therefore weighted toward assigning nonsomnolent ratings. 
Data Analysis 
Histograms were plotted to assess the distribution of con-
tinuous variables, and scatterplots were inspected to 
evaluate the possibility of nonlinear relationships between 
variables. Z-tests for point estimates when population 
means are known were used to determine deviance from 
population norms. Chi-square tests were used for cate-
gorical data, two-tailed t-tests and Pearson product-
moment correlations for continuous variables, and multiple 
regression analyses were used to partial out the effects of 
several different factors measured. In addition, in the re-
gression of IQ on radiation dosage and age at irradiation, 
we included as an independent variable an interaction term, 
namely, the product of rads and age at irradiation. 
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RESULTS 
Inspection of the histograms demonstrated sufficient 
variability and distributions appropriate to satisfy the 
assumptions of normality for statistical procedures. Inspec-
tion of scatterplots of full scale, verbal, and performance 
IQ (FSIQ, VIQ, PIQ) against the continuous variables of 
socioeconomic status (SES), age at irradiation, and follow-
up interval revealed only linear relationships between the 
various dependent and independent variables. 
Cognitive Functioning of the Entire Sample 
This study was not designed and is not intended to assess 
whether as a group, children with acute lymphoblastic 
leukemia (ALL) exhibit cognitive deficits. However, it is of 
some interest to compare the cognitive functioning of this 
sample to available normative data. Mean FSIQ 
(98.5 ± 19.2), VIQ (98.6 ± 20.1), and PIQ (98.9 ± 18.9) in 
this sample were not significantly different than population 
norms{µ= 100±15). Of the 10 subtests of the Wechsler 
intelligence tests, only information (x = 8.6 ± 4.0) and 
arithmetic (x =8.8 ± 3.0) were significantly different 
(p < 0.01) from population norms (µ = 10 ± 3). There was 
no difference between this sample and population norms 
on reading achievement (x =99.9± 15.3; µ= 100± 15.3; 
µ= 100 ± 15), but arithmetic (x =95.1±15.8) and spelling 
(x = 94.2±15.9) achievement were both significantly lower. 
Socioeconomic Status 
The mean SES of the entire sample was 2.6 ± 1.3. Social 
class was highly correlated with all three measures of IQ 
(VIQ: r = - 0.67, p < 0.001; PIQ: r = - 0.31, p < 0.05; 
FSIQ: r = - 0.60, p < 0.001). 
Somnolence 
Of the 39 subjects who met inclusion criteria, 18 (460Jo) 
were rated somnolent. These subjects were significantly 
older when irradiated than nonsomnolent subjects 
[75.4 ± 33.8 vs 52.6 ± 25.3 months, t(37) = 2.41,p < 0.05] 
but did not differ in age at examination (117. 7 ± 37.4 
vs 105.1 ± 31.2 months), follow-up interval (42.9 ± 25.8 vs 
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b n = 17. 
c Age standard scores. 
d n = 15. 
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All differences nonsignificant. Abbreviations: VIQ, verbal IQ; PIO, per-
formance IQ; FSIQ, full-scale IQ; PIAT, Peabody Individual Achievement 
Test. 
52.4 ± 24.9 months), radiation dosage (2106 ± 305 
vs 2187 ± 285 rads), or sex distribution (560Jo vs 520Jo male). 
Although not statistically significant, there were more lower 
social class subjects [Hollingshead class IV, V) in the non-
somnolent (6/18) than somnolent (3/16) groups [X2 (1 
dD=0.33, p<0.54]. Three nonsomnolent and two som-
nolent subjects refused psychometric testing; subsequent 
analyses are based on 34 subjects. 
Table 1 shows a 13-point difference in VIQ between som-
nolent and nonsomnolent groups. This difference only ap-
proaches significance [!(31) = 2.00, p < 0.06], and is in the 
opposite of predicted direction, the somnolent group 
having a higher VIQ. Other IQ and achievement test dif-
ferences are also nonsignificant. 
If young age at irradiation predicts later cognitive prob-
lems, lower VIQ might have resulted from the younger age 
at irradiation of nonsomnolent subjects. In an analysis of 
covariance, controlling for age at irradiation, higher VIQ 
remained nonsignificantly related to somnolence 
(F1,29= 2.92, p < 0.10). 
Age at Irradiation and Irradiation-Examination 
(Follow-up) Interval 
Because we chose to examine subjects at least 5 years old, 
children who were older at diagnosis are likely to have 
shorter follow-up intervals. Therefore, these two variables 
are related to each other (r = 0.31,p < 0.05), but their inde-
pendent contribution is considered here. The Pearson 
product-moment correlations of IQ and age at irradiation 
and follow-up interval are shown in Table 2. No significant 
relationship was found. Achievement scores were not sig-
nificantly correlated with age at irradiation or follow-up 
interval. 
Radiation Dosage 
Radiation dosage was dichotomized (high = 2400 rads, 
low= 1800 rads). Higher dosage was weakly (nonsig-
nificantly) correlated (point biserial) with lower IQ scores 
(Table 2), and was unrelated to achievement scores. We 
TABLE 2. Pearson Correlations of IQ and Achievement with Age 
at Irradiation, Follow-up Interval, and Radiation Dosage and Social 
Class 
Age 














- 0.246 - 0.225 - 0.672° 
-0.118 -0.181 -0.319d 
-0.219 -0.189 -0.6000 
0.186 -0.138 -0.559° 
0.070 -0.069 -0.511 1 
0.110 -0.165 -0.544° 
• Follow-up = age at examination minus age at irradiation. 
b WISC-A or WPPSI. 
c p < 0.001. 
d p < 0.05. 
• Age standard scores. 
1 p < 0.01, all other correlations nonsignificant. 
Abbreviations: SES, socioeconomic status; VIQ, verbal IQ; PIO, per-
formance IQ; FSIQ, full-scale IQ; PIAT, Peabody Individual Achieve-
ment Test. 
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found no interaction between radiation dosage and age at 
irradiation. 
Finally, to assess the relative importance of the various 
factors that have been reported to contribute to lower IQ, 
we conducted four two-variable stepwise regression analy-
ses. In each regression equation, VIQ was first regressed on 
SES, the variable with, by far, the strongest zero-order rela-
tion to IQ. SES accounted for 45% of the variance in VIQ 
(Table 3). In step two, one of four variables (somnolence, 
age at irradiation, follow-up interval, rads) was entered. 
This method allows one to assess the relative importance of 
each variable in predicting VIQ. None of the four step-two 
variables accounted for significant additional variance in 
VIQ after SES was entered. Somnolence approached sig-
nificance but in the opposite of expected direction 
(F1,30 = 3.93, p = 0.057). The four two-variable stepwise 
regressions were repeated using PIQ and FSIQ as the out-
come. Again, no significant additional variance was found. 
TABLE 3. Two-step Regression: R2 Increase in IQ After Controlling 
for SES 
Somnolence 
Age at irradiation 
Follow-up interval 
Rads 
R2 for SES alone 
•p = 0.057. 
b p < 0.001. 
VIQ 






c p < 0.05, all others nonsignificant. 
PIQ FSIQ 






Abbreviations: SES, socioeconomic status; VIQ, verbal IQ; PIO, per-
formance IQ; FSIQ, full-scale IQ. 
DISCUSSION 
This study examined four factors which may contribute 
to intellectual deficits in children treated for acute 
lymphoblastic leukemia (ALL): somnolence syndrome, 
age at irradiation, follow-up interval, and radiation 
dosage. The subjects included a total clinic population of 
irradiated ALL patients in continuous complete remission 
who were 5-14 years old at the time of examination, ex-
cluding only those patients whose intellectual abilities 
might have been lowered by factors other than those under 
study, such as central nervous system (CNS) or systemic 
relapse (with added chemotherapy and/or CNS irradia-
tion), seizures, or Down syndrome. The same psycho-
logical measures were used on all subjects, and social class 
was statistically controlled for. Only one28 of the pre-
viously published studies examined the relative contri-
bution of possibly deleterious factors (social class and age 
at diagnosis) to outcome as this report does. 
We could not confirm the direct relationship between 
somnolence syndrome and "learning difficulties" as reported 
by Ch'ien et al, 2 a finding also unconfirmed by other 
studies.29•30 Because our information on somnolence syn-
drome was derived from retrospective record review, it is 
possible that some misclassification took place. However, 
our somnolence rate of 46% is similar to that reported in 
nine other studies (overall mean for 698 subjects: 430/o, 
range 10-780Jo )2•3•29-30 and to the 51 % rate reported for pro-
spective studies only (range 36-660Jo).2•29- 32•34 We might 
expect that if misclassification was obscuring a real relation-
ship between somnolence syndrome and intelligence (IQ), 
than a comparison of cases with positive chart notation of 
somnolence syndrome (n = 7) to cases free of somnolence 
symptoms (n = 17) (thus excluding ambiguous cases) might 
yield a significant difference. This analysis approaches statis-
tical significance, but in the opposite of predicted direction. 
Specifically, somnolent subjects had higher verbal IQ (VIQ) 
(109.3 vs 92.1", t= 1.98,p<0.06) and were significantly older 
(78. 7 vs 50.6 months, t = 2.2, p< 0.05) than nonsomnolent 
subjects. 
Neither did we find significant differences between 
somnolent and nonsomnolent subjects on achievement 
measures. A more recent report by Ch'ien's group,29 with a 
much larger sample size, shows similiar means and stan-
dard deviations and no significant differences between 
somnolent and nonsomnolent groups. Perhaps the dis-
crepancy between our results and those of Ch'ien et al,2 in 
their original paper, can be accounted for by the latter's 
inclusion of one subject who developed leukoen-
cephalopathy after treatment with high dose intravenous 
methotrexate and cranial irradiation (Ch'ien, 1980, per-
sonal communication). 
We did not find lower IQ in subjects who were younger 
at irradiation or had longer follow-up intervals. The 
literature on these factors is far from consistent. Although 
three of the better-controlled studies found lower IQ in 
younger irradiated subjects,6-8 others have failed to 
demonstrate a significant relationship.9-12 Reports oflower 
IQ in longer irradiation-examination interval subjects12-1s 
are unreliable, in that follow-up interval and age at irradi-
ation are confounded. None of these studies controls for 
social class or age at irradiation differences. It is possible 
that there are delayed effects on IQ which subside over 
time. We found no obvious nonlinear pattern in the 
scatterplot of IQ versus follow-up interval, but since this 
study is not longitudinal, it is possible that the inter-
individual variations in IQ would obscure a pattern that 
would emerge in longitudinal data. 
We found a nonsignificant trend for higher radiation 
dosage to be associated with lower IQ, but young age at 
irradiation and high n~diation dosage do not appear to 
interact. Examination of a larger sample of low- and high-
dose subjects would be valuable. If such a study sub-
stantiated an inverse relationship between radiation 
dosage and IQ, a switch to lower radiation dosage treat-
ment regimens would be indicated, since CNS prophylaxis 
with 1800 rads has been shown to be as effective as with 
2400 rads. 36 
As noted above, this study was not designed to assess 
whether treatment of ALL leads to cognitive deficits. To 
study this issue, ideally one would need prediagnosis IQ 
and achievement data. This is impractical, because it 
would require testing an extremely large number of 
children to obtain a cohort who eventually developed this 
rare disorder. Postdiagnosis but pretreatment test results 
126 TRAUTMAN ET AL JDBP/June, Vol. 9, No. 3 
would not necessarily reflect the premorbid functioning of 
these severely ill children. Premorbid school records 
would be of interest, but would vary from school to 
school. Further, many newly diagnosed children have not 
yet attended school. 
In the absence of premorbid data, an appropriate com-
parison group would allow assessment of the effect of 
leukemia and its treatment on cognitive functioning. Un-
affected siblings might serve as a control group for family 
influences of heredity and environment. Children with 
other forms of cancer who do not receive intrathecal 
medication or cranial irradiation might serve as controls for 
effects of illness and missed school. These control groups 
have been utilized in other studies which were specifically 
designed t9 assess whether there is a cognitive deficit caused 
by this disease. 
The currently available literature about the effects of 
cranial irradiation on IQ is not consistent. Whereas a few 
studies demonstrate lower IQ in irradiated leukemic 
children than in nonirradiated controls,6·7·16,37 a greater 
number do not.6·10·12-13•28·38-44 (The negative studies are 
generally, but not uniformly, less well-designed.) Some 
studies that purport to show IQ differences include subjects 
with CNS leukemia and systemic relapse,44- 45 or do not 
clearly exclude subjects with other possible cause for low 
IQ, such as seizures or encephalopathy.9.31 
In the present study, no control group was utilized, since 
it was designed to assess the effect of several treatment fac-
tors within a total patient population. Comparison of the 
data from this sample to population norms should be inter-
preted with caution. Cognitive functioning in leukemia pa-
tients can be adversely affected by treatment and yet not fall 
below normal range. If, for some reason, the patient popu-
lation is biased toward higher premorbid levels of cognitive 
functioning, even substantial declines from premorbid levels 
could result in "normal" test scores. The present sample pro-
vides an example of such a possible bias. The mean social 
class of this sample (2.6 ± 1.3) is significantly higher than 
in the general population (µ=3.7±1.0, p<0.001). The 
unstandardized regression coefficients from a regression 
analysis of IQ on socioeconomic status (SES), age at irradia-
tion, and somnolence indicate that in this sample, a decrease 
of one level of SES leads to an 8. 7-point decrease in full scale 
IQ (FSIQ) and a 10.0-point decrease in VIQ. As the sample 
mean SES is approximately one level higher than the popu-
lation mean, we might expect sample mean IQ to have been 
higher than the population mean IQ at baseline. The fact 
that, after treatment, the sample IQ mean is slightly lower 
than population norms could represent a decline in.intellec-
tual functioning. Without premorbid data or appropriate 
age, SES, and treatment-matched controls, it is not possible 
to say what overall effect, if any, treatment has had on these 
subjects. 
We found that our subjects scored significantly lower 
than population norms on information and arithmetic sub-
tests of the Wechsler scales and on Peabody arithmetic and 
spelling achievement tests, but not reading comprehension. 
The available literature shows no consistent pattern of de-
ficiencies in Wechsler subtestsMo,41 or achievement tests 
(three reported no differences from controls,38.4l,43 one 
reported lower WRA T arithmetic but not word recognition 
or spelling,40 and one reported superior arithmetic achieve-
ment) in irradiated versus nonirradiated leukemic 
subjects.28 Again, our study was not designed to evaluate 
this issue, and further research needs to be done on the pat-
tern of deficits in these children. 
We wish to emphasize the importance of controlling for 
social class (as measured by parental education and occu-
pation) in this research area. In our sample, children of 
social classes 4 and 5 had significantly lower VIQ and FSIQ 
than subjects in social classes 1, 2, and 3. Parental social 
class is a good predictor of a child's IQ and achievement.46 
It is easy to see how nonrandom distribution of social class 
can bias cognitive findings in a small sample. Most reports 
do not control for social class;9•10-14.16·30·38-45·47.48 only Moss 
et al,6 Eiser,7 Eiser and Lansdown,8 Whitt et al, 28 and 
Jannoun37 do. 
A methodological difficulty that affects the present study 
is its small sample size. Since the sample represents a total 
patient population in the given age range, biases present 
should be limited to those introduced by the selection by 
age. Although there are children in the sample who were 
diagnosed and irradiated when as young as 14 months old, 
there are no recently diagnosed children who are younger 
than 5 years old. However, IQ assessment below the age of 5 
is not reliable, and available instruments do not correlate 
well with Wechsler scales. The sample is too small to explore 
adequately the effecis that this age restriction introduces. 
However, since there is a complete range of age at diagnosis 
and irradiation, bias will hopefully be minimal and not 
affect the interpretation and generalization of positive 
findings. 
More problematic is the interpretation of negative 
findings. Lack of statistical significance at p = 0.05 level 
does not prove the null hypothesis. The sample size in this 
study provides us with a power of 0.80 to detect a 15-point 
(one standard deviation) difference between group means in 
IQ and achievement !-tests. However, smaller group dif-
ferences of 10 or even 7.5 points could be clinically im-
portant. In this study, we only have power of 0.28 on t- tests 
and 0.30 on regression analyses to detect differences be-
tween groups of 7 .5 IQ points. This is clearly inadequate. A 
sample size of 126 subjects (63/group) would be required to 
detect a 7 .5 IQ-point difference with a power of0.80. Such a 
sample size will require a multicenter study. 
In summary, our data support previously published re-
ports that postirradiation somnolence syndrome does not 
predict later cognitive dysfunction. Somnolence is more fre-
quently observed in older children. The data do not support 
young age at irradiation or longer diagnosis-examination 
interval as predictors of cognitive dysfunction. The trend 
toward lower IQ in children receiving higher radiation 
dosages bears further investigation. Our data, which show 
the powerful contribution of social class to cognitive out-
come, cast doubt on other reports of irradiated leukemia 
patients which fail to control for social class differences 
among subjects and control groups. Despite the logistic dif-
ficulties inherent in such work, multicenter research is advo-
cated to obtain sample sizes that provide adequate power to 
detect important effects on IQ and academic achievement. 
, 
l 
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